RxDoctor Payments DataLook up a doctor →

Craig Coleby, MD

Internal Medicine · Riverton, UTNPI 1386825024

Payments from drug & device makers

$11,768in general payments, 2019–2025

Across 636 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lilly USA, LLC$914
  • Boehringer Ingelheim$764
  • AstraZeneca$687
  • Active Medical, LLC$467
  • Pfizer$438
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)159$2,777
Lilly USA, LLC60$914
Boehringer Ingelheim44$764
AstraZeneca40$687
Active Medical, LLC1$467
Pfizer30$438
Novo Nordisk26$411
Lundbeck LLC21$381
Supernus Pharmaceuticals, Inc.12$315
Ironshore Pharmaceuticals Inc.14$278
Arthrex5$275
Amgen16$274
Abbott13$267
Tersera Therapeutics LLC9$266
Corcept Therapeutics10$244
Sanofi-aventis U.S. LLC14$206
Corium, LLC11$200
Tris Pharma Inc10$184
Takeda Pharmaceuticals U.S.A., Inc.10$161
GSK8$134
Azurity Pharmaceuticals, Inc.8$127
Axsome Therapeutics, Inc.5$120
Amarin Pharma, Inc.7$113
Cranial Technologies, Inc6$110
Johnson & Johnson(2 entities)5$101
Merck6$95
CSL Behring3$90
Biohaven Pharmaceuticals, Inc.5$77
Eisai Inc.4$77
Phathom Pharmaceuticals, Inc.5$72
Medtronic4$71
Biohaven Pharmaceutical Holding Company Ltd.5$65
Sobi, Inc4$60
Cycle Pharmaceuticals Inc2$59
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$57
Dynavax Technologies Corporation4$56
Collegium Pharmaceutical, Inc.3$49
Antares Pharma, Inc.3$45
Adlon Therapeutics L.p.3$44
Xeris Pharmaceuticals, Inc.3$44
Otsuka America Pharmaceutical, Inc.2$44
Inspire Medical Systems, Inc.2$43
Teva Pharmaceuticals USA, Inc.3$41
Radius Health, Inc.2$37
Upsher-smith Laboratories LLC2$36
Alfasigma USA, Inc.2$33
Exact Sciences2$28
Bayer2$27
Lucid Diagnostics Inc.2$27
Arbor Pharmaceuticals, Inc.2$26
Biocryst US Sales Co., LLC1$26
Vertex1$25
Almatica Pharma LLC1$22
Organon1$22
Mylan Specialty L.p.1$19
Sunovion Pharmaceuticals Inc.1$18
Ferring Pharmaceuticals Inc.1$18
Bioventus LLC1$18
Tandem Diabetes Care, Inc.1$18
Shire North American Group Inc1$15

How this compares

$11,768 in reported general payments places this provider in the 90th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$40,150
Medicare patients
85
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Riverton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →